Open Journal of Endocrine and Metabolic Diseases
Vol.3 No.7(2013), Paper ID 39668, 8
pages
DOI:10.4236/ojemd.2013.37036
Metformin Modulates GLP-1- and GIP-Mediated Intracellular Signaling under Normoglycemic Conditions
Kyoko Shinmura, Takaharu Negoro, Shunichi Shimizu, Giovanna Roncador, Tsutomu Hirano, Yasuko Nakano
Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan
Department of Pharmacogenomics, Showa University School of Pharmacy, Tokyo, Japan
Department of Pathophysiology, Showa University School of Pharmacy, Tokyo, Japan
Monoclonal Antibodies Unit, Biotechnology Program, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain
Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, Showa University School of Medicine, Tokyo, Japan
Department of Pharmacogenomics, Showa University School of Pharmacy, Tokyo, Japan
Copyright © 2013 Kyoko Shinmura, Takaharu Negoro, Shunichi Shimizu, Giovanna Roncador, Tsutomu Hirano, Yasuko Nakano et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Shinmura, K. , Negoro, T. , Shimizu, S. , Roncador, G. , Hirano, T. and Nakano, Y. (2013) Metformin Modulates GLP-1- and GIP-Mediated Intracellular Signaling under Normoglycemic Conditions.
Open Journal of Endocrine and Metabolic Diseases,
3, 263-270. doi:
10.4236/ojemd.2013.37036.